- Home
- SOHU vs STRO Comparison
SOHU vs STRO Comparison
Compare SOHU & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOHU | STRO |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.1M | 381.1M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SOHU | STRO |
|---|---|---|
| Price | $14.28 | $21.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $20.00 | ★ $31.33 |
| AVG Volume (30 Days) | 45.0K | ★ 279.6K |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $38,419,000.00 |
| Revenue This Year | $1.61 | N/A |
| Revenue Next Year | $3.78 | N/A |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.61 | $0.72 |
| 52 Week High | $17.30 | $43.85 |
Technical Indicators
Market Signals| Indicator | SOHU | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 38.68 |
| Support Level | $12.97 | $18.74 |
| Resistance Level | $14.83 | $27.16 |
| Average True Range (ATR) | 0.65 | 1.91 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 47.14 | 37.38 |
Price Performance
Historical ComparisonAbout SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.